Bonadio A, Wenig B, Hockla A, Radisky E, Shifman J
J Mol Biol. 2023; 435(13):168095.
PMID: 37068580
PMC: 10312305.
DOI: 10.1016/j.jmb.2023.168095.
Eckfeld C, Schoeps B, Haussler D, Fradrich J, Bayerl F, Bottcher J
J Cell Biol. 2023; 222(2).
PMID: 36629908
PMC: 9837626.
DOI: 10.1083/jcb.202206095.
Tsokolas G
Medicine (Baltimore). 2022; 101(38):e30595.
PMID: 36197222
PMC: 9509119.
DOI: 10.1097/MD.0000000000030595.
Spano D, Scilabra S
Membranes (Basel). 2022; 12(2).
PMID: 35207132
PMC: 8878240.
DOI: 10.3390/membranes12020211.
Costello L, DiColandrea T, Tasseff R, Isfort R, Bascom C, von Zglinicki T
Aging Cell. 2022; 21(2):e13550.
PMID: 35037366
PMC: 8844123.
DOI: 10.1111/acel.13550.
TIMP3 involvement and potentiality in the diagnosis, prognosis and treatment of diabetic nephropathy.
Casagrande V, Federici M, Menghini R
Acta Diabetol. 2021; 58(12):1587-1594.
PMID: 34181080
PMC: 8542557.
DOI: 10.1007/s00592-021-01766-y.
Restoration of renal TIMP3 levels via genetics and pharmacological approach prevents experimental diabetic nephropathy.
Casagrande V, Iuliani G, Menini S, Pugliese G, Federici M, Menghini R
Clin Transl Med. 2021; 11(2):e305.
PMID: 33634991
PMC: 7862169.
DOI: 10.1002/ctm2.305.
Matrix metalloproteinase-9 as a messenger in the cross talk between obstructive sleep apnea and comorbid systemic hypertension, cardiac remodeling, and ischemic stroke: a literature review.
Mashaqi S, Mansour H, Alameddin H, Combs D, Patel S, Estep L
J Clin Sleep Med. 2020; 17(3):567-591.
PMID: 33108267
PMC: 7927322.
DOI: 10.5664/jcsm.8928.
Recent insights into natural product inhibitors of matrix metalloproteinases.
Kumar G, Nair B, Perry J, Martin D
Medchemcomm. 2020; 10(12):2024-2037.
PMID: 32904148
PMC: 7451072.
DOI: 10.1039/c9md00165d.
Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
Raeeszadeh-Sarmazdeh M, Do L, Hritz B
Cells. 2020; 9(5).
PMID: 32466129
PMC: 7290391.
DOI: 10.3390/cells9051313.
TIMP1 intron 3 retention is a marker of colon cancer progression controlled by hnRNPA1.
Flodrops M, Dujardin G, Busson A, Trouve P, Ka C, Simon B
Mol Biol Rep. 2020; 47(4):3031-3040.
PMID: 32200451
DOI: 10.1007/s11033-020-05375-w.
Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition.
Raeeszadeh-Sarmazdeh M, Greene K, Sankaran B, Downey G, Radisky D, Radisky E
J Biol Chem. 2019; 294(24):9476-9488.
PMID: 31040180
PMC: 6579469.
DOI: 10.1074/jbc.RA119.008321.
A bi-specific inhibitor targeting IL-17A and MMP-9 reduces invasion and motility in MDA-MB-231 cells.
Koslawsky D, Zaretsky M, Alcalay R, Mazor O, Aharoni A, Papo N
Oncotarget. 2018; 9(47):28500-28513.
PMID: 29983876
PMC: 6033355.
DOI: 10.18632/oncotarget.25526.
Tissue inhibitor of metalloproteinases 1 enhances rod survival in the rd1 mouse retina.
Kim H, Vargas A, Eom Y, Li J, Yamamoto K, Craft C
PLoS One. 2018; 13(5):e0197322.
PMID: 29742163
PMC: 5942829.
DOI: 10.1371/journal.pone.0197322.
Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
Wang X, Khalil R
Adv Pharmacol. 2018; 81:241-330.
PMID: 29310800
PMC: 5765875.
DOI: 10.1016/bs.apha.2017.08.002.
Intrinsic dynamics study identifies two amino acids of TIMP-1 critical for its LRP-1-mediated endocytosis in neurons.
Verzeaux L, Belloy N, Thevenard-Devy J, Devy J, Ferracci G, Martiny L
Sci Rep. 2017; 7(1):5375.
PMID: 28710453
PMC: 5511134.
DOI: 10.1038/s41598-017-05039-z.
Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
Liu J, Khalil R
Prog Mol Biol Transl Sci. 2017; 148:355-420.
PMID: 28662828
PMC: 5548434.
DOI: 10.1016/bs.pmbts.2017.04.003.
Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.
Radisky E, Raeeszadeh-Sarmazdeh M, Radisky D
J Cell Biochem. 2017; 118(11):3531-3548.
PMID: 28585723
PMC: 5621753.
DOI: 10.1002/jcb.26185.
Direct expression of active human tissue inhibitors of metalloproteinases by periplasmic secretion in Escherichia coli.
Lee K, Nam D, Nuhn J, Wang J, Schneider I, Ge X
Microb Cell Fact. 2017; 16(1):73.
PMID: 28454584
PMC: 5410052.
DOI: 10.1186/s12934-017-0686-9.
Glycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunities.
Boon L, Ugarte-Berzal E, Vandooren J, Opdenakker G
Biochem J. 2016; 473(11):1471-82.
PMID: 27234584
PMC: 4888457.
DOI: 10.1042/BJ20151154.